(813) 971-8080

7210 Wareham Drive, Tampa, FL 33647

Our Mission

To Bring Those Tracking the Weight Loss Market The Latest Industry News and Company Developments, Marketdata Commentary and Opinions. To Provide An Ongoing Forum for Discussion and Feedback for Those Working in The Weight Loss Field.

The Most Comprehensive Study About The U.S. Weight Loss Market–Since 1989

The U.S. Weight Loss & Diet Control Market

March 2023       427 Pages      160 tables/charts       Price: $1,995

The $75 billion U.S. weight loss market grew nearly 15% last year from the depressed level of 2020.  Most segments of the market have recovered from the Covid-19 pandemic and recession. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy and Saxenda, with more new drugs coming soon. The market may be entering a new era of medical approaches. Even Weight Watchers is now providing a medical plan.

The frozen diet entrees market and diet soft drinks have shown surprising strength, but the health clubs industry was devasted by the pandemic and emerges as a smaller sector. Supply chain disruptions affected the MLM market for meal replacements into 2021 and 2022, tamping down growth for Herbalife and Medifast. The ranks of commercial weight loss centers have been thinned out, and chains had to pivot to virtual client meetings and drop shipping of
products.

Do-it-yourself plans still abound as consumers use free diet & fitness apps. Many untapped niches still exist.  This is a completely revised and updated analysis of Marketdata’s best-selling biennial study about the U.S. weight loss market. This is the most comprehensive investigation of the U.S. weight loss market published by anyone worldwide.

Covered… dollar value & growth rates of all major weight loss market segments (early 1980s to 2022 and 2023 & 2027 forecasts), latest market trends and developments, status reports for: diet soft drinks, artificial sweeteners, health clubs, commercial diet center chains, multi-level marketing diet plans, retail meal replacements & weight loss supplements, medical programs (weight loss surgery, MDs, hospitals/clinic programs, Rx diet drugs, bariatricians, VLCD programs), low-cal frozen entrees, and the diet books & exercise DVDs market.

New for this edition:

  • Effects of the Pandemic on operations & revenues for all market segments, analysis of the recovery
  • How dieter behavior changed with the pandemic
  • The skyrocketing market for Rx obesity drugs and MD programs
  • 2022 market performance, 2023 & 2027 Forecasts
  • The most popular diets today
  • Ranking of the leading competitor companies
  • Outlook for the 2023 diet season
  • Why MLM is a major force in meal replacements sales, tough year in 2022
  • The franchising slowdown.

Also included: 34-year revenue analysis of the market through past recessions and fad diet cycles, comprehensive dieter demographics, weight loss center franchising, and extensive national/state commercial centers’ operating ratios. Rankings & revenues of top commercial chains, brand sales, and a Reference Directory. Contains 34 in-depth competitor profiles for: Weight Watchers, Jenny Craig, NutriSystem, Medifast, Herbalife, Noom, Slim-Fast, Atkins Nutritionals, HMR, Optifast, Robard, Lindora Clinics, Slimgenics, Ideal Protein, Profile by Sanford, BeachBody, Metabolic Research, Smart For Life, Medi-Weightloss, Centers for Medical Weight Loss, Nuviva, JumptStart MD, Dr. G’s, more.

Report also sold by individual chapters at lower price. $99 Overview available.

 

Latest News

Telehealth Weight Loss Market Worth $6.9 Billion And Growing

April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for weight loss programs delivered via telehealth / telemedicine companies is worth $6.9 billion, and growing. Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their physicians via Zoom video calls and by phone, email and chat. The number of telehealth companies exploded. Then, in 2021-2023, as demand for the GLP-1

Read More »

Oprah’s TV Special Falls Short

March 19, 2024 Last night Oprah Winfrey hosted a TV special investigating the popular GLP-1 diet drugs. The stories by people who lost significant weight were good, as was the information about obesity being a disease and not just a lack of willpower. However, in our opinion, some very important topics were not even mentioned. First, why does Oprah consider it a conflict of interest for her to be on these meds and be on the Weight Watcher’s Board? WW

Read More »

Eli Lilly Offers Access To Zepbound via Amazon

March 14, 2024 The U.S. pharmaceutical giant Eli Lilly is partnering with Amazon to help distribute its prescription drugs, notably its new weight loss treatment called Zepbound. Eli Lilly is using Amazon Pharmacy to distribute Zepbound to people’s homes through the drug maker’s new direct-to-consumer program. Going forward, Amazon Pharmacy will deliver drugs from Eli Lilly that are prescribed for obesity, diabetes or migraine headaches to patients who order them through the pharma company’s direct sales website. LillyDirect, the new

Read More »

U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs

March 4, 2024 U.S. Weight Loss Market Now Worth $90 Billion, Obesity Drug Sales Soar March 4, 2024 Marketdata LLC has just published a new analysis of the weight loss market: “The U.S. Weight Loss Market: 2024 Status Report & Forecast”, March 2024, 107 Pages Some findings: The total U.S. weight loss market is estimated to have grown to a historic peak of $90 billion in 2023, boosted by soaring sales of the popular prescription GLP-1 weight loss drugs. This

Read More »

Marketdata weight loss reports have been quoted by..

Scroll to Top